Several studies have demonstrated the efficacy of inhibitors of IL-6, IL-17, and TNF-α in the management of chronic plaque psoriasis and psoriatic arthritis (Hughes and Chinoy, 2013; Bakshi et al., 2020; Tsai and Tsai, 2017). The gene discussed is TNF; the disease is psoriatic arthritis.